Skip to main content

Year: 2023

Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC

New Drug Application granted priority review with PDUFA date set for June 10, 2024 European Medicines Agency (EMA) has also validated the Marketing Authorization Application (MAA) for elafibranor Investigational elafibranor is the first novel second-line treatment for primary biliary cholangitis (PBC) to be filed in E.U. and U.S. in nearly a decadeParis (France), December 07, 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) and GENFIT (Nasdaq and Euronext: GNFT) today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for investigational elafibranor. An oral, once-daily dual peroxisome activated receptor alpha/delta (PPAR α,δ) agonist, investigational elafibranor could potentially be the first novel second-line treatment for the rare, cholestatic liver disease, PBC, in nearly a decade....

Continue reading

Share Buyback Transaction Details November 30 – December 6, 2023

                                         Share Buyback Transaction Details November 30 – December 6, 2023 December 7, 2023 – Wolters Kluwer (Euronext: WKL), a global leading provider of expert solutions, insights and services for professionals, today reports that it has repurchased 241,578 of its own ordinary shares in the period from November 30, 2023, up to and including December 6, 2023, for €31.0 million and at an average share price of €128.18. These repurchases are part of the share buyback program announced on February 22, 2023, under which we intend to repurchase shares for up to €1 billion during 2023. The cumulative amounts repurchased to date under this year’s buyback program are as follows: Share Buyback 2023Period Cumulative shares repurchased in period Total consideration(€ million) Average share price(€)2023...

Continue reading

Hearing Aids Market Size, Share & Growth Analysis, [2030] | With CAGR of 8.4%

As per the report by Fortune Business Insights, the Hearing Aids Market size is projected to surpass USD 21.09 billion by 2030, at a CAGR of 8.4% during 2023-2030.Hearing Aids MarketHearing Aids Market (2023-2030)Pune, India, Dec. 07, 2023 (GLOBE NEWSWIRE) — The global hearing aids market size is valued at USD 11.98 billion in 2023, and it is projected to be valued at USD 21.09 billion by 2030, recording a CAGR of 8.4% during the forecast period. Market was valued at USD 11.29 billion in 2022. Hearing aids are small electronic devices that help people suffering from mild to moderate hearing loss and impairment hear clearly. The growing incidence of hearing loss & impairment among people across the world, especially the geriatric population, is one of the major factors that will boost the hearing aids market growth. Fortune...

Continue reading

Nurse Call Systems Market Size, Share & Growth Analysis, [2030] | With CAGR of 13.4%

As per the report by Fortune Business Insights, the global Nurse Call Systems Market size is projected to reach USD 4.47 billion in 2030, at a CAGR of 13.4% during the forecast period, 2023-2030Nurse Call Systems MarketNurse Call Systems Market (2023-2030)Pune, India, Dec. 07, 2023 (GLOBE NEWSWIRE) — The global Nurse Call Systems Market size was valued at USD 1.62 billion in 2022 and is expected to be worth USD 1.86 billion in 2023, it is projected to reach USD 4.47 billion by 2030, recording a CAGR of 13.4% during the forecast period. Fortune Business Insights™ reports that the increasing work pressure on nurses and the decreasing patient-to-nurse ratio is driving the demand for products in the healthcare sector. This insight is derived from their report titled “Nurse Call Systems Market, 2023-2030.”Request...

Continue reading

Hip Replacement Market Size, Share & Growth Analysis, [2030] | With CAGR of 4.9%

According to a Fortune Business Insights analysis, the size of the global hip replacement market is expected to grow at a compound annual growth rate (CAGR) of 4.9% and reach USD 10.79 billion by 2030.Hip Replacement MarketHip Replacement Market (2023-2030)Pune, India, Dec. 07, 2023 (GLOBE NEWSWIRE) — The global hip replacement market size was valued at USD 7.42 billion in 2022. The market is projected to grow from USD 7.72 billion in 2023 to USD 10.79 billion by 2030, exhibiting a CAGR of 4.9% over the study period. The rise is propelled by the increasing prevalence of osteoarthritis and favorable government initiatives.   Fortune Business Insights™ provides this information in its research report, titled “Hip Replacement Market, 2023-2030”.Key Industry Development: February 2021 – MicroPort Orthopedics expanded...

Continue reading

Menstrual Cups Market Size, Share & Growth Analysis, [2030] | With CAGR of 6.1%

The global menstrual cups market size was USD 1.36 billion in 2022 and is anticipated to hit USD 2.15 billion by 2030, exhibiting a CAGR of 6.1%.Menstrual Cups MarketForecast 2023-2030Pune, India, Dec. 07, 2023 (GLOBE NEWSWIRE) — The global menstrual cups market size was USD 1.36 billion in 2022 market is estimated to expand from USD 2.15 billion by 2030 exhibiting a CAGR of 6.1% over the analysis period. The product adoption is being impelled by an upsurge in innovation by industry players. Several companies are offering technologically advanced products in various sizes and shapes.     Fortune Business Insights™ provides this information in its research report, titled “Menstrual Cups Market, 2023-2030”.Request a Free Sample PDF : https://www.fortunebusinessinsights.com/enquiry/sample/menstrual-cups-market-108492Key...

Continue reading

Nasdaq Appoints Roland Chai as President of European Market Services

STOCKHOLM, Sweden, Dec. 07, 2023 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announces the appointment of Roland Chai as President of European Market Services, effective 1 January 2024. In this role, he will lead Nasdaq´s multi-asset trading, clearing, listings, and market services businesses across Europe, including Sweden, Denmark, Finland, Iceland, Estonia, Latvia, and Lithuania stock exchanges. Nasdaq´s European markets has been a fundamental engine of innovation, economic growth and prosperity in the Nordic and Baltic regions. Nasdaq’s European Market Services has a strong legacy of technology leadership, marketplace excellence and strong commitment to sustainability. Beyond its role as a market operator, Nasdaq continues to be an integral part of the financial ecosystem that drives the development of more competitive,...

Continue reading

New Final Bond Terms for Nykredit Realkredit A/S’s Base Prospectus dated 12 May 2023

To                Nasdaq Copenhagen A/S        New Final Bond Terms for Nykredit Realkredit A/S’s Base Prospectus dated 12 May 2023 In connection with the opening of new ISINs under Nykredit Realkredit A/S’s Base Prospectus dated 12 May 2023, Nykredit issues new Final Bond Terms. The Final Bond Terms for series 13H, 32H and 32G are stated below. Nykredit Realkredit A/S’s Base Prospectus dated 12 May 2023 and the relevant Final Bond Terms are available for download in Danish and English. In the event of discrepancies between the original Danish text and the English translation, the Danish text shall prevail. The documents can be found on Nykredit’s website at nykredit.com/ir.ISINSeries Currency Bond type Maturity IT/RF*DK0009545279 32H DKK Cita3 + interest rate spread (Callable) 01.04.2027 RFDK0009545352 32H DKK Cibor3...

Continue reading

Change in the composition of Sydbank’s Group Executive Management

Company Announcement No 42/2023Peberlyk 46200 Aabenraa, Denmark Tel +45 70 10 78 79Fax +45 74 37 35 36 Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk7 December 2023  Dear Sirs Change in the composition of Sydbank’s Group Executive Management The position of Deputy Group Chief Executive with responsibility for Credits and Compliance etc. is handed over to a new member of the Group Executive Management from the Bank’s own ranks. Member of the Group Executive Management and Deputy Group Chief Executive Bjarne Larsen resigns from his position in this connection. Sydbank’s current Group Executive Vice President, Credits, Stig Westergaard, is appointed as Deputy Group Chief Executive with responsibility for Credits and Compliance etc. – The Board of Directors has decided to change the composition of the Group Executive Management....

Continue reading

Advantest Targets NAND Flash/NVM Market with New Group of Memory Test Products

Offerings Include Wafer-Level Test Solution, System-Level Test Module, and High-Speed Wafer-Sort InterfaceT5835T5835 Memory Test SystemT5851 STM32GT5851-STM32G moduleT5230T5230 Memory Test SystemTOKYO, Dec. 07, 2023 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) today announced three new additions to its suite of memory test products. The new offerings are designed to target NAND Flash and non-volatile memory (NVM) devices, which face extreme pressure to bring down test costs and cost of ownership on the test floor. The new products include the T5230 memory wafer test solution; the STM32G third-generation protocol NAND system-level test module for the T5851 memory tester; and the T5835 high-speed wafer-sort interface option. The T5230 memory test...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.